CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex assay (HIV 1/2, HBV and HCV), performed on the Tigris testing platform, to the -enhanced Ultrio Elite triplex assay performed on the Panther testing platform on July 13, 2020. The implementation date has been moved up to July 7th. Contact your Customer Service Manager if you have any questions!
Reminder - Dr. Buff Mair is the new CTS Medical Director. Several of the CTS client forms specify li...
Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA test...
On December 9, 2019, the new CTS Laboratory Information System successfully implemented in Phoe...
The new online Learning Center with new content can still be found under the “Training” folder on ...
We received an updated WNV package insert; please note the manufacturer and license number has been ...
We sincerely hope to see you at this year’s AABB Annual Meeting in San Antonio, TX on October ...